You just read:

Statement from Acting FDA Commissioner Ned Sharpless, M.D., on continued efforts to increase availability of all forms of naloxone to help reduce opioid overdose deaths

News provided by

U.S. Food and Drug Administration

Sep 20, 2019, 11:29 ET